Mutations and intronic variants in the HNF-1beta gene in a group of German and Czech Caucasians with type 2 diabetes mellitus and progressive diabetic nephropathy

Summary

Mutations in the hepatocyte nuclear factor - 1β (HNF-1β) gene cause maturity onset diabetes of the young type 5 (MODY 5). A clinical feature of the resulting phenotype besides impaired glucose tolerance is a variety of renal abnormalities, ranging from renal cysts to end-stage renal failure. Using a candidate gene approach we investigated the prevalence of mutations in the HNF-1β gene in a group of 63 patients from two different European populations (33 Germans, 30 Czechs) with type 2 diabetes mellitus and diabetic nephropathy diagnosed by increased albuminuria (39 patients) or end-stage renal failure (24 patients). No mutations were found in any of the 9 exons or in a minimal promoter region. Three intronic variants (single nucleotide polymorphisms - SNPs) were detected. The frequencies of these variants showed no difference between the two studied populations and were comparable to data reported from healthy subjects. No association between SNPs or formed haplotypes and any clinical parameters (like age of disease onset, BMI and severity of renal failure) was found. The results confirm that the genetic variations in the HNF-1β gene would be a very uncommon cause of progressive nephropathy in patients with type 2 diabetes mellitus.

Key words:

HNF-1β gene - TCF2 - MODY - Type 2 diabetes mellitus - Diabetic nephropathy

References

• 1 Beards F, Frayling T, Bulman M, Horikawa Y, Allen L, Appleton M, Bell G I, Ellard S, Hattersley A T. Mutations in hepatocyte nuclear factor 1beta are not a common cause of maturity-onset diabetes of the young in the U.K.  Diabetes. 1998;  47 1152-1154
• 2 Bingham C, Ellard S, Allen L, Bulman M, Shepherd M, Frayling T, Berry P J, Clark P M, Lindner T, Bell G I, Ryffel G U, Nicholls A J, Hattersley A T. Abnormal nephron development associated with a frameshift mutation in the transcription factor hepatocyte nuclear factor-1 beta.  Kidney Int. 2000;  57 898-907
• 3 Horikawa Y, Iwasaki N, Hara M, Furuta H, Hinokio Y, Cockburn B N, Lindner T, Yamagata K, Ogata M, Tomonaga O, Kuroki H, Kasahara T, Iwamoto Y, Bell G I. Mutation in hepatocyte nuclear factor-1 beta gene (TCF2) associated with MODY.  Nat Genet. 1997;  17 384-385
• 4 Horikawa Y, Oda N, Cox N J, Li X, Orho-Melander M, Hara M, Hinokio Y, Lindner T H, Mashima H, Schwarz P E, del Bosque-Plata L, Oda Y, Yoshiuchi I, Colilla S, Polonsky K S, Wei S, Concannon P, Iwasaki N, Schulze J, Baier L J, Bogardus C, Groop L, Boerwinkle E, Hanis C L, Bell G I. Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus.  Nat Genet. 2000;  26 163-175
• 5 Iwasaki N, Babazono T, Tomonaga O, Ogata M, Yokokowa H, Iwamoto Y. Mutation in the hepatocyte nuclear factor-1 beta (MODY5) gene are not a major factor contributing to end-stage renal disease in Japanese people with diabetes mellitus.  Diabetologia. 2001;  44 127-128
• 6 Lindner T H, Njolstad P R, Horikawa Y, Bostad L, Bell G I, Sovik O. A novel syndrome of diabetes mellitus, renal dysfunction and genital malformation associated with a partial deletion of the pseudo-POU domain of hepatocyte nuclear factor-1beta.  Hum Mol Genet. 1999;  8 2001-2008
• 7 Weng J P, Lehto M, Forsblom C, Huang X, Li H, Groop L C. Hepatocyte nuclear factor-1 beta (MODY5) gene mutations in Scandinavian families with early-onset diabetes or kidney disease or both.  Diabetologia. 2000;  43 131-132